logologo
QuantliQuantli

Janux Therapeutics Inc

JANX

NASDAQ

Biotechnology

$16.12

USD

+0.12 (+0.75%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $978.19M

Volume 441.5K

Price Target

$26.00$26.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $26.00 and a min estimate of $26.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$26.00

-$13.6 vs prior

Implied Upside

+61.3%

-84.2% vs prior

Analyst Covering

1

-6 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

13%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Supawat Thongthip

Truist Securities

Buy

Resumed

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

GERN

Geron Corp

$1.47

-4.2%

ARDX

Ardelyx Inc

$4.06

+3.8%

DSGN

Design Therapeutics Inc

$14.83

+3.1%

ODTX

Odyssey Therapeutics Inc

$20.73

+0.1%

SLDB

Solid Biosciences Inc

$9.20

+1.3%

AVTX

Avalo Therapeutics Inc

$19.59

+0.7%

OLMA

Olema Pharmaceuticals Inc

$10.63

+1.1%

CLYM

Climb Bio Inc

$16.33

+10.9%

KURA

Kura Oncology Inc

$10.86

+7.6%